Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program

This study compared initiation of insulin and other antihyperglycaemic agents (AHAs) with canagliflozin versus placebo for participants with type 2 diabetes and a history/high risk of cardiovascular disease in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program. After 1 year, fewer pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, David R., Wysham, Carol, Davies, Melanie, Slee, April, Alba, Maria, Lee, Mary, Perkovic, Vlado, Mahaffey, Kenneth W., Neal, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693248/
https://www.ncbi.nlm.nih.gov/pubmed/32691499
http://dx.doi.org/10.1111/dom.14143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693248/
https://www.ncbi.nlm.nih.gov/pubmed/32691499
http://dx.doi.org/10.1111/dom.14143

Ejemplares similares